EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy



Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy



Retina 20(5): 554-555




(PDF same-day service: $19.90)

Accession: 035985944

Download citation: RISBibTeXText

PMID: 11039438

DOI: 10.1097/00006982-200005000-00024



Related references

Visualization of the vitreous and posterior hyaloid during pars plana vitrectomy using triamcinolone acetonide. IOVS 41(4): S347, March 15, 2000

Introduction of a new method for the preparation of triamcinolone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 23(6): 881-882, 2004

Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane. Retina 27(2): 174-179, 2007

Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy. Klinika Oczna 108(1-3): 24-27, 2006

Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Japanese Journal of Ophthalmology 50(6): 529-531, 2006

Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy. Retina 29(1): 38-45, 2008

The effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema. Clinical Ophthalmology 8(): 825-830, 2014

Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. Acta Ophthalmologica Scandinavica 85(6): 603-608, 2007

Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy. Japanese Journal of Ophthalmology 49(6): 538-539, 2005

A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy. International Ophthalmology 27(1): 51-54, 2007

Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery. Eye 21(5): 591-594, 2006

Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide. Klinika Oczna 110(4-6): 151-154, 2008

Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy. Graefe's Archive for Clinical and Experimental Ophthalmology 242(8): 679-681, 2004

Intravitreal triamcinolone acetonide injection at the time of pars plana vitrectomy for retained lens material. Korean Journal of Ophthalmology 23(1): 13-16, 2009

Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. British Journal of Ophthalmology 87(8): 1010-1014, 2003